{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:11:18Z","timestamp":1782234678084,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","award":["88881.132132\/2016-01"],"award-info":[{"award-number":["88881.132132\/2016-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["442855\/2019-2"],"award-info":[{"award-number":["442855\/2019-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Statins are cholesterol-lowering drugs commonly used among people with HIV, associated with an increased risk of myopathies. Considering that cardiovascular disease, statin therapy, and sarcopenia are independently prevalent in people with HIV, clarity on the potential benefits or harms of statin therapy on muscle health is useful to provide insight into ways to maximize skeletal muscle health and minimize CVD risk in this population. We aimed to study the effects of statin therapy on strength, muscle mass, and physical function parameters in people with HIV. This was a pilot cross-sectional study. People with HIV on continuous statin therapy (<jats:italic>n<\/jats:italic>\u2009=\u200952) were paired 1:1 according to age (people with HIV 53.9\u2009\u00b1\u20098.2 and people with HIV on statins 53.9\u2009\u00b1\u20098.4\u00a0years), sex, body mass index (Body mass index, people with HIV 28.6\u2009\u00b1\u20095.3 and people with HIV on statins 28.8\u2009\u00b1\u20096.3\u00a0kg\/m<jats:sup>2<\/jats:sup>), and race with people with HIV not using statin (<jats:italic>n<\/jats:italic>\u2009=\u200952). Participants were evaluated for muscle strength (i.e. handgrip strength), lean and fat body mass (using bioelectric impedance analysis), and physical function (i.e. Short Physical Performance Battery\u2014SPPB). Isokinetic strength and appendicular lean mass (using dual-energy X-ray absorptiometry), more accurate strength and body composition measures, were determined in 38% of the participants. Overall, statin usage does not exacerbated loss of muscle strength (32.2\u2009\u00b1\u200911.5 vs. 30.3\u2009\u00b1\u20099.6\u00a0kg, <jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05) muscle mass (7.6\u2009\u00b1\u20091.8 vs. 7.7\u2009\u00b1\u20091.1\u00a0kg\/m<jats:sup>2<\/jats:sup>, <jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05), and impaired physical performance (10.1\u2009\u00b1\u20091.8 vs. 9.7\u2009\u00b1\u20092.1 points, <jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05) of PLWH. When analyzed by sex, men living with HIV on statins usage presented higher appendicular muscle mass (28.4\u2009\u00b1\u20093.1 vs. 26.2\u2009\u00b1\u20094.9\u00a0kg, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) handgrip strength (42.1\u2009\u00b1\u20098.8 vs. 37.1\u2009\u00b1\u20098.3\u00a0kg, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and physical function through SPPB score (10.9\u2009\u00b1\u20091.3 vs. 9.5\u2009\u00b1\u20092.1, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) than men living with HIV not on statins treatment. The same protection was not observed in women. This data was demonstrated when muscle mass and strength were determined clinically (i.e. handgrip strength and electrical impedance) and when more precise laboratory measurements of muscle mass and strength were conducted (i.e. isokinetic strength and DXA scans). Statin does not exacerbate muscle wasting, strength loss, or muscle dysfunction among people with HIV. Indeed, statins may protect men, but not woman with HIV against HIV and antiretroviral therapy-induced loss of muscle mass and strength.<\/jats:p>","DOI":"10.1038\/s41598-023-31643-3","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T13:06:22Z","timestamp":1679490382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Statin protects men but not women with HIV against loss of muscle mass, strength, and physical function: a pilot study"],"prefix":"10.1038","volume":"13","author":[{"given":"Jos\u00e9 David G.","family":"C\u00e1rdenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor H. F.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L.","family":"Borsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poliana C.","family":"Marinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris T.","family":"Longenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Deminice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"31643_CR1","doi-asserted-by":"publisher","first-page":"e207954","DOI":"10.1001\/jamanetworkopen.2020.7954","volume":"3","author":"JL Marcus","year":"2020","unstructured":"Marcus, J. L. et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000\u20132016. JAMA Netw. Open 3, e207954 (2020).","journal-title":"JAMA Netw. Open"},{"key":"31643_CR2","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1097\/QAD.0000000000001444","volume":"31","author":"KL Hawkins","year":"2017","unstructured":"Hawkins, K. L. et al. Geriatric syndromes: New frontiers in HIV and sarcopenia. AIDS 31, S137\u2013S146. https:\/\/doi.org\/10.1097\/QAD.0000000000001444 (2017).","journal-title":"AIDS"},{"key":"31643_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/JNC.0000000000000240","volume":"32","author":"AR Webel","year":"2021","unstructured":"Webel, A. R., Schexnayder, J., Cioe, P. A. & Zu\u00f1iga, J. A. A review of chronic comorbidities in adults living with HIV: State of the science. J. Assoc. Nurses AIDS Care 32, 322\u2013346 (2021).","journal-title":"J. Assoc. Nurses AIDS Care"},{"key":"31643_CR4","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","volume":"140","author":"MJ Feinstein","year":"2019","unstructured":"Feinstein, M. J. et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: A scientific statement from the American Heart Association. Circulation 140, e98\u2013e124. https:\/\/doi.org\/10.1161\/CIR.0000000000000695 (2019).","journal-title":"Circulation"},{"key":"31643_CR5","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S2352-3018(20)30036-9","volume":"7","author":"KGS So-Armah","year":"2020","unstructured":"So-Armah, K. G. S. et al. HIV and cardiovascular disease. Lancet HIV 7, e279\u2013e293. https:\/\/doi.org\/10.1016\/S2352-3018(20)30036-9 (2020).","journal-title":"Lancet HIV"},{"key":"31643_CR6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1080\/14740338.2020.1796966","volume":"19","author":"R Mulchandani","year":"2020","unstructured":"Mulchandani, R., Lyngdoh, T. & Kakkar, A. K. Statin use and safety concerns: An overview of the past, present and the future. Expert Opin. Drug Saf. 19, 1011\u20131024 (2020).","journal-title":"Expert Opin. Drug Saf."},{"key":"31643_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","volume":"120","author":"A Oesterle","year":"2017","unstructured":"Oesterle, A., Laufs, U. & Liao, J. K. Pleiotropic effects of statins on the cardiovascular system. Circ. Res. 120, 229\u2013243 (2017).","journal-title":"Circ. Res."},{"key":"31643_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3162-1","volume":"18","author":"OA Uthman","year":"2018","unstructured":"Uthman, O. A. et al. Statin use and all-cause mortality in people living with HIV: A systematic review and meta-analysis. BMC Infect. Dis. 18, 1\u20138 (2018).","journal-title":"BMC Infect. Dis."},{"key":"31643_CR9","doi-asserted-by":"publisher","first-page":"104201","DOI":"10.1016\/j.phrs.2019.03.010","volume":"154","author":"J Bouitbir","year":"2020","unstructured":"Bouitbir, J. et al. Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacol. Res. 154, 104201. https:\/\/doi.org\/10.1016\/j.phrs.2019.03.010 (2020).","journal-title":"Pharmacol. Res."},{"key":"31643_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ahj.2014.03.019","volume":"168","author":"HV Ganga","year":"2014","unstructured":"Ganga, H. V., Slim, H. B. & Thompson, P. D. A systematic review of statin-induced muscle problems in clinical trials. Am. Heart J. 168, 6\u201315 (2014).","journal-title":"Am. Heart J."},{"key":"31643_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3949\/ccjm.78a.10073","volume":"78","author":"G Fernandez","year":"2011","unstructured":"Fernandez, G., Spatz, E. S., Jablecki, C. & Phillips, P. S. Statin myopathy: A common dilemma not reflected in clinical trials. Cleve Clin. J. Med. 78, 393\u2013403 (2011).","journal-title":"Cleve Clin. J. Med."},{"key":"31643_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2020-043714","volume":"11","author":"JW Davis","year":"2021","unstructured":"Davis, J. W. & Weller, S. C. Intensity of statin therapy and muscle symptoms: A network meta-analysis of 153 000 patients. BMJ Open 11, 1\u201312 (2021).","journal-title":"BMJ Open"},{"key":"31643_CR13","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","volume":"388","author":"R Collins","year":"2016","unstructured":"Collins, R. et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 388, 2532\u20132561 (2016).","journal-title":"Lancet"},{"key":"31643_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11904-014-0215-y","volume":"11","author":"KM Erlandson","year":"2014","unstructured":"Erlandson, K. M. et al. Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr. HIV\/AIDS Rep. 11, 279\u2013290 (2014).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"31643_CR15","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1097\/QAD.0000000000001245","volume":"30","author":"JA Schrack","year":"2016","unstructured":"Schrack, J. A. et al. Effect of HIV-infection and cumulative viral load on age-related decline in grip strength. AIDS 30, 2645\u20132652 (2016).","journal-title":"AIDS"},{"key":"31643_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/QAI.0000000000000731","volume":"70","author":"JA Schrack","year":"2015","unstructured":"Schrack, J. A. et al. Accelerated longitudinal gait speed decline in HIV-infected older men. JAIDS J. Acquir. Immune Defic. Syndr. 70, 370\u2013376 (2015).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"31643_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/2325957413495919","volume":"13","author":"P Wasserman","year":"2014","unstructured":"Wasserman, P., Segal-Maurer, S. & Rubin, D. S. High prevalence of low skeletal muscle mass associated with male gender in midlife and older HIV-infected persons despite CD4 cell reconstitution and viral suppression. J. Int. Assoc. Provid. AIDS Care 13, 145\u2013152 (2014).","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"key":"31643_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/QAI.0000000000001835","volume":"79","author":"M Gomes-Neto","year":"2018","unstructured":"Gomes-Neto, M., Rodriguez, I., L\u00e9do, A. P., Vieira, J. P. B. & Brites, C. Muscle strength and aerobic capacity in HIV-infected patients. JAIDS J. Acquir. Immune Defic. Syndr. 79, 491\u2013500 (2018).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"31643_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft, A. J. et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 48, 16\u201331 (2019).","journal-title":"Age Ageing"},{"key":"31643_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1249\/JES.0000000000000282","volume":"50","author":"R Deminice","year":"2022","unstructured":"Deminice, R., Oliveira, V. H. F., Webel, A. R. & Erlandson, K. M. Sarcopenia related to human immunodeficiency virus: Protective effects of exercise. Exerc. Sport Sci. Rev. 50, 73\u201380 (2022).","journal-title":"Exerc. Sport Sci. Rev."},{"key":"31643_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41430-020-0637-0","volume":"74","author":"VHF Oliveira","year":"2020","unstructured":"Oliveira, V. H. F., Borsari, A. L., Webel, A. R., Erlandson, K. M. & Deminice, R. Sarcopenia in people living with the human immunodeficiency virus: A systematic review and meta-analysis. Eur. J. Clin. Nutr. 74, 1009\u20131021 (2020).","journal-title":"Eur. J. Clin. Nutr."},{"key":"31643_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/QAI.0000000000002579","volume":"86","author":"M Abdo","year":"2021","unstructured":"Abdo, M. et al. Effect of statin therapy on age-associated changes in physical function among men with and without HIV in the multicenter AIDS cohort study. J. Acquir. Immune Defic. Syndr. 86, 455\u2013462 (2021).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"31643_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/aid.2015.0191","volume":"32","author":"KM Erlandson","year":"2016","unstructured":"Erlandson, K. M., Jiang, Y., Debanne, S. M. & Mccomsey, G. A. Effects of 96 weeks of rosuvastatin on bone, muscle, and fat in HIV-infected adults on effective antiretroviral therapy. AIDS Res. Hum. Retrovir. 32, 311\u2013316 (2016).","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"31643_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1249\/MSS.0000000000002120","volume":"52","author":"HR Zanetti","year":"2020","unstructured":"Zanetti, H. R. et al. Effects of exercise training and statin use in people living with human immunodeficiency virus with dyslipidemia. Med. Sci. Sports Exerc. 52, 16\u201324 (2020).","journal-title":"Med. Sci. Sports Exerc."},{"key":"31643_CR25","first-page":"3","volume-title":"Anthropometric Standardizing Reference Manual","author":"CC Gordon","year":"1988","unstructured":"Gordon, C. C., Chumlea, W. C. & Roche, A. F. Stature, recumbent length and weight. In Anthropometric Standardizing Reference Manual (eds Lohman, T. G. et al.) 3\u20138 (Human Kinetics Books, 1988)."},{"key":"31643_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/ajcn\/68.4.786","volume":"68","author":"LB Sardinha","year":"1998","unstructured":"Sardinha, L. B., Lohman, T. G., Teixeira, P. J., Guedes, D. P. & Going, S. B. Comparison of air displacement plethysmography with dual-energy X-ray absorptiometry and 3 field methods for estimating body composition in middle-aged men. Am. J. Clin. Nutr. 68, 786\u2013793 (1998).","journal-title":"Am. J. Clin. Nutr."},{"key":"31643_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0261-5614(03)00048-7","volume":"22","author":"U Kyle","year":"2023","unstructured":"Kyle, U., Genton, L., Hans, D. & Pichard, C. Validation of a bioelectrical impedance analysis equation to predict appendicular skeletal muscle mass (ASMM). Clin. Nutr. 22, 537\u2013543 (2023).","journal-title":"Clin. Nutr."},{"key":"31643_CR28","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik, J. M. et al. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J. Gerontol. 49, M85\u2013M94 (1994).","journal-title":"J. Gerontol."},{"key":"31643_CR29","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1249\/MSS.0000000000001920","volume":"51","author":"T Morville","year":"2019","unstructured":"Morville, T. et al. Aerobic exercise performance and muscle strength in statin users\u2014The LIFESTAT study. Med. Sci. Sports Exerc. 51, 1429\u20131437 (2019).","journal-title":"Med. Sci. Sports Exerc."},{"key":"31643_CR30","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00421-020-04360-2","volume":"120","author":"AM Schweitzer","year":"2020","unstructured":"Schweitzer, A. M., Gingrich, M. A., Hawke, T. J. & Rebalka, I. A. The impact of statins on physical activity and exercise capacity: An overview of the evidence, mechanisms, and recommendations. Eur. J. Appl. Physiol. 120, 1205\u20131225 (2020).","journal-title":"Eur. J. Appl. Physiol."},{"key":"31643_CR31","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jacl.2017.07.003","volume":"11","author":"AM Noyes","year":"2017","unstructured":"Noyes, A. M. & Thompson, P. D. The effects of statins on exercise and physical activity. J. Clin. Lipidol. 11, 1134\u20131144 (2017).","journal-title":"J. Clin. Lipidol."},{"key":"31643_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fgene.2012.00328","volume":"3","author":"RL Smith","year":"2013","unstructured":"Smith, R. L. et al. Premature and accelerated aging: HIV or HAART?. Front. Genet. 3, 328. https:\/\/doi.org\/10.3389\/fgene.2012.00328 (2013).","journal-title":"Front. Genet."},{"key":"31643_CR33","doi-asserted-by":"publisher","first-page":"e0181568","DOI":"10.1371\/journal.pone.0181568","volume":"12","author":"KP Derose","year":"2017","unstructured":"Derose, K. P. et al. Factors contributing to food insecurity among women living with HIV in the Dominican Republic: A qualitative study. PLoS One 12, e0181568. https:\/\/doi.org\/10.1371\/journal.pone.0181568 (2017).","journal-title":"PLoS One"},{"key":"31643_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12981-018-0213-z","volume":"15","author":"ML Giles","year":"2018","unstructured":"Giles, M. L., Gartner, C. & Boyd, M. A. Smoking and HIV: What are the risks and what harm reduction strategies do we have at our disposal?. AIDS Res. Ther. 15, 26 (2018).","journal-title":"AIDS Res. Ther."},{"key":"31643_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.maturitas.2016.11.006","volume":"96","author":"G Bano","year":"2017","unstructured":"Bano, G. et al. Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas 96, 10\u201315 (2017).","journal-title":"Maturitas"},{"key":"31643_CR36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/QAI.0000000000000478","volume":"68","author":"NT Funderburg","year":"2015","unstructured":"Funderburg, N. T. et al. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-Iinfected subjects on antiretroviral therapy. JAIDS J. Acquir. Immune Defic. Syndr. 68, 396\u2013404 (2015).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"31643_CR37","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.7150\/ijbs.42965","volume":"16","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q., Dong, J. & Yu, Z. Pleiotropic use of statins as non-lipid-lowering drugs. Int. J. Biol. Sci. 16, 2704\u20132711 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"31643_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11904-018-0383-2","volume":"15","author":"EP Scully","year":"2018","unstructured":"Scully, E. P. Sex differences in HIV infection. Curr. HIV\/AIDS Rep. 15, 136\u2013146 (2018).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"31643_CR39","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1042\/CS20160112","volume":"130","author":"M Griesbeck","year":"2016","unstructured":"Griesbeck, M., Scully, E. & Altfeld, M. Sex and gender differences in HIV-1 infection. Clin. Sci. 130, 1435\u20131451 (2016).","journal-title":"Clin. Sci."},{"key":"31643_CR40","doi-asserted-by":"publisher","first-page":"e25868","DOI":"10.1002\/jia2.25868","volume":"25","author":"CT Longenecker","year":"2022","unstructured":"Longenecker, C. T. et al. Sex modifies the association between HIV and coronary artery disease among older adults in Uganda. J. Int. AIDS Soc. 25, e25868. https:\/\/doi.org\/10.1002\/jia2.25868 (2022).","journal-title":"J. Int. AIDS Soc."},{"key":"31643_CR41","doi-asserted-by":"publisher","first-page":"e018767","DOI":"10.1161\/JAHA.120.018767","volume":"10","author":"J Kipke","year":"2021","unstructured":"Kipke, J. et al. Sex, HIV status, and measures of cardiac stress and fibrosis in Uganda. J. Am. Heart Assoc. 10, e018767. https:\/\/doi.org\/10.1161\/JAHA.120.018767 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"31643_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3851\/IMP3159","volume":"23","author":"VH Oliveira","year":"2017","unstructured":"Oliveira, V. H. et al. Muscle strength is impaired in men but not in women living with HIV taking antiretroviral therapy. Antivir. Ther. 23, 11\u201319 (2017).","journal-title":"Antivir. Ther."},{"key":"31643_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/QAI.0000000000002629","volume":"87","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Human immunodeficiency virus Iinfection and incident heart failure: A meta-analysis of prospective studies. JAIDS J. Acquir. Immune Defic. Syndr. 87, 741\u2013749 (2021).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"31643_CR44","doi-asserted-by":"publisher","first-page":"CD008226","DOI":"10.1002\/14651858.CD008226.pub3","volume":"12","author":"SP Adams","year":"2015","unstructured":"Adams, S. P. et al. Atorvastatin for lowering lipids. Cochrane Database Syst. Rev. 12, CD008226. https:\/\/doi.org\/10.1002\/14651858.CD008226.pub3 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"31643_CR45","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/GME.0000000000001412","volume":"26","author":"SS Faubion","year":"2019","unstructured":"Faubion, S. S., Kapoor, E., Moyer, A. M., Hodis, H. N. & Miller, V. M. Statin therapy: Does sex matter?. Menopause 26, 1425\u20131435 (2019).","journal-title":"Menopause"},{"key":"31643_CR46","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1517\/14740338.2015.1039980","volume":"14","author":"M Banach","year":"2015","unstructured":"Banach, M. et al. Statin intolerance\u2014An attempt at a unified definition. Position paper from an International Lipid Expert Panel. Expert Opin. Drug Saf. 14, 935\u201355 (2015).","journal-title":"Expert Opin. Drug Saf."},{"key":"31643_CR47","unstructured":"U.S. Food & Drug Administration. FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-interactions-between-certain-hiv-or-hepatitis-c-drugs-and-cholesterol (2016)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31643-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31643-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31643-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T13:17:53Z","timestamp":1679491073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31643-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["31643"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-31643-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4693"}}